Submitted by Anonymous (not verified) on 12 March 2026 - 11:20
Opinion/decision on a Paediatric investigation plan (PIP): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: EMA/PE/0000226217
Source: